Strong order intake in all areas with increasing revenue share of biological solutions and injectables New platform wins reinforce position as strategic partner of choice for the global pharma and…
Two leading companies introduce EZ-fill Smart™, the new Ready-To-Fill solution platform for the global vial market Customers benefit from reduced Total Cost of Ownership, lower process complexity…
To accelerate and de-risk drug development, Gerresheimer AG and Nelson Labs NV announce a formal strategic partnership on analytical and drug compatibility lab testing for the Pharmaceutical and…
Proof of Concept (PoC) successfully provides primary packaging with a unique ID to access its own trustworthy digital twin Users gain immediate access to quality and process data of products at…
Duesseldorf/Vaerloese, October 26, 2022. With DropControl, Gerresheimer has developed a new dropper insert for modern drugs with low viscosity for ophthalmology, which prevents the drug from flowing…
Organic revenue growth of 17.4% in the third quarter supported by continued strong demand for High Value Solutions Organic adjusted EBITDA up 13.3% Gerresheimer firmly on track to deliver on FY…
